{
    "type": "esummary",
    "version": "0.3",
    "documentsummaryset": {
        "status": "OK",
        "195331": {
            "uid": "195331",
            "d_study_results": {
                "d_study_id": "",
                "d_study_name": "",
                "d_study_ancestor": [
                ],
                "d_study_genotype_platform_list": [
                ],
                "d_num_descendants_in_subtree": 0,
                "d_num_variables_in_subtree": 0,
                "d_num_documents_in_subtree": 0,
                "d_num_analyses_in_subtree": 0,
                "d_num_participants_in_subtree": 0,
                "d_study_type": "",
                "d_study_type_list": [
                ],
                "d_study_status": "",
                "d_study_embargo_date": "",
                "d_study_release_date": "",
                "d_study_project_list": [
                ],
                "d_study_disease_list": [
                ],
                "d_study_has_sra": "",
                "d_study_archive": ""
            },
            "d_variable_results": {
                "d_variable_id": "phs000201.v1.p1&phv=76164|phv00076164.v1.p1",
                "d_variable_name": "Abnormal/Total Cells (clone 5)",
                "d_variable_ancestor": [
                    {
                        "d_ancestor_id": "phs000201.v1.p1",
                        "d_ancestor_name": "Acquired Copy Number Alterations in Adult Acute Myeloid Leukemia Genomes"
                    }
                ],
                "d_variable_parent": [
                    {
                        "d_parent_id": "phs000201.v1.p1",
                        "d_parent_name": "Acquired Copy Number Alterations in Adult Acute Myeloid Leukemia Genomes"
                    }
                ],
                "d_variable_dataset": {
                    "d_variable_dataset_name": "AML_Data",
                    "d_variable_dataset_id": "pht000885.v1.p1",
                    "d_variable_dataset_description": "This data table contains subject phenotypes (case-control status, sex, and age variables; n=7) and tumor sample phenotypes (immunophenotype and differential counts, cytogenetic and molecular abnormalities (n=27 variables).  Included also are subject treatment protocol and any transplant type (n=2 variables)."
                },
                "d_variable_description": "# of abnormal cells in clone 5/total cells evaluated  (if applicable)",
                "d_variable_type": " ",
                "d_variable_embargo_date": " ",
                "d_variable_phenx": " ",
                "d_variable_has_phenx": " "
            },
            "d_document_results": {
                "d_document_id": "",
                "d_document_name": "",
                "d_document_ancestor": [
                ],
                "d_document_parent": [
                ],
                "d_document_description": ""
            },
            "d_analysis_results": {
                "d_analysis_id": "",
                "d_analysis_name": "",
                "d_analysis_ancestor": [
                ],
                "d_analysis_parent": [
                ],
                "d_analysis_description": ""
            },
            "d_dataset_results": {
                "d_dataset_id": "",
                "d_dataset_name": "",
                "d_dataset_ancestor": [
                ],
                "d_dataset_parent": [
                ],
                "d_dataset_description": "",
                "d_dataset_embargo_date": ""
            }
        }
    }
}
